CN1141580C - 对艾滋病与丙型肝炎病毒抗体的联合快速检测方法 - Google Patents
对艾滋病与丙型肝炎病毒抗体的联合快速检测方法 Download PDFInfo
- Publication number
- CN1141580C CN1141580C CNB011071966A CN01107196A CN1141580C CN 1141580 C CN1141580 C CN 1141580C CN B011071966 A CNB011071966 A CN B011071966A CN 01107196 A CN01107196 A CN 01107196A CN 1141580 C CN1141580 C CN 1141580C
- Authority
- CN
- China
- Prior art keywords
- antibody
- quick
- bag
- damping fluid
- detected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000030507 AIDS Diseases 0.000 title claims abstract description 9
- 208000005176 Hepatitis C Diseases 0.000 title abstract 2
- 238000003556 assay Methods 0.000 title description 14
- 230000003612 virological effect Effects 0.000 title description 3
- 238000001514 detection method Methods 0.000 claims abstract description 103
- 239000000427 antigen Substances 0.000 claims abstract description 51
- 102000036639 antigens Human genes 0.000 claims abstract description 51
- 108091007433 antigens Proteins 0.000 claims abstract description 51
- 238000009792 diffusion process Methods 0.000 claims abstract description 38
- 239000000126 substance Substances 0.000 claims abstract description 36
- 238000002372 labelling Methods 0.000 claims abstract description 35
- 230000008021 deposition Effects 0.000 claims abstract description 15
- 241000700605 Viruses Species 0.000 claims abstract description 11
- 239000007853 buffer solution Substances 0.000 claims abstract description 11
- 108010074605 gamma-Globulins Proteins 0.000 claims abstract description 10
- 208000011580 syndromic disease Diseases 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 71
- 238000013016 damping Methods 0.000 claims description 62
- 239000012530 fluid Substances 0.000 claims description 62
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 32
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 32
- 238000007789 sealing Methods 0.000 claims description 30
- 230000008878 coupling Effects 0.000 claims description 29
- 238000010168 coupling process Methods 0.000 claims description 29
- 238000005859 coupling reaction Methods 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 29
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 25
- 239000012528 membrane Substances 0.000 claims description 25
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 21
- 238000012412 chemical coupling Methods 0.000 claims description 20
- 239000000084 colloidal system Substances 0.000 claims description 20
- 239000010931 gold Substances 0.000 claims description 19
- 229910052737 gold Inorganic materials 0.000 claims description 19
- 238000010521 absorption reaction Methods 0.000 claims description 17
- 239000008363 phosphate buffer Substances 0.000 claims description 17
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 239000001103 potassium chloride Substances 0.000 claims description 16
- 235000011164 potassium chloride Nutrition 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 15
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 15
- 235000019800 disodium phosphate Nutrition 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- MHKBMNACOMRIAW-UHFFFAOYSA-N 2,3-dinitrophenol Chemical compound OC1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O MHKBMNACOMRIAW-UHFFFAOYSA-N 0.000 claims description 12
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000003365 glass fiber Substances 0.000 claims description 12
- 230000008595 infiltration Effects 0.000 claims description 12
- 238000001764 infiltration Methods 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- 239000003989 dielectric material Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- FYEHYMARPSSOBO-UHFFFAOYSA-N Aurin Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)=C1C=CC(=O)C=C1 FYEHYMARPSSOBO-UHFFFAOYSA-N 0.000 claims description 9
- 241001060848 Carapidae Species 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 239000002250 absorbent Substances 0.000 claims description 8
- 230000002745 absorbent Effects 0.000 claims description 8
- 229920002301 cellulose acetate Polymers 0.000 claims description 8
- 238000013327 media filtration Methods 0.000 claims description 8
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- JETSRCJOKRWZAI-UHFFFAOYSA-N [N+](=O)([O-])C=1C(=C(C=CC1)O)[N+](=O)[O-].[N+](=O)([O-])C=1C(=C(C=CC1)O)[N+](=O)[O-] Chemical compound [N+](=O)([O-])C=1C(=C(C=CC1)O)[N+](=O)[O-].[N+](=O)([O-])C=1C(=C(C=CC1)O)[N+](=O)[O-] JETSRCJOKRWZAI-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 238000009877 rendering Methods 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 7
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- LUVOJBWJNHWVNG-UHFFFAOYSA-N [Na].[Na].[Na].OC(=O)CC(O)(C(O)=O)CC(O)=O Chemical compound [Na].[Na].[Na].OC(=O)CC(O)(C(O)=O)CC(O)=O LUVOJBWJNHWVNG-UHFFFAOYSA-N 0.000 claims description 6
- 239000000956 alloy Substances 0.000 claims description 6
- 229910045601 alloy Inorganic materials 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 6
- 239000013049 sediment Substances 0.000 claims description 6
- 208000006454 hepatitis Diseases 0.000 claims description 5
- 231100000283 hepatitis Toxicity 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 230000004069 differentiation Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229920000151 polyglycol Polymers 0.000 claims description 3
- 239000010695 polyglycol Substances 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 238000005199 ultracentrifugation Methods 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 229940127121 immunoconjugate Drugs 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- DFIWJEVKLWMZBI-UHFFFAOYSA-M sodium;dihydrogen phosphate;phosphoric acid Chemical compound [Na+].OP(O)(O)=O.OP(O)([O-])=O DFIWJEVKLWMZBI-UHFFFAOYSA-M 0.000 claims 1
- 239000011248 coating agent Substances 0.000 abstract description 8
- 238000000576 coating method Methods 0.000 abstract description 8
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 53
- 238000012360 testing method Methods 0.000 description 50
- 241000711549 Hepacivirus C Species 0.000 description 49
- 210000002966 serum Anatomy 0.000 description 28
- 238000002474 experimental method Methods 0.000 description 16
- 239000000047 product Substances 0.000 description 13
- 239000003547 immunosorbent Substances 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000001262 western blot Methods 0.000 description 7
- 239000013642 negative control Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000036436 anti-hiv Effects 0.000 description 5
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000011895 specific detection Methods 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000581002 Murex Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- OJYGBLRPYBAHRT-IPQSZEQASA-N chloralose Chemical compound O1[C@H](C(Cl)(Cl)Cl)O[C@@H]2[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]21 OJYGBLRPYBAHRT-IPQSZEQASA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- DEQXHPXOGUSHDX-UHFFFAOYSA-N methylaminomethanetriol;hydrochloride Chemical compound Cl.CNC(O)(O)O DEQXHPXOGUSHDX-UHFFFAOYSA-N 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010971 suitability test Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
实验号 | 信/噪比 | 结果 | 实验号 | 信/噪比 | 结果 |
1 | 6.11 | (+) | 11 | 5.07 | (+) |
2 | 2.41 | (+) | 12 | 5.46 | (+) |
3 | 4.22 | (+) | 13 | 1.07 | (+) |
4 | 4.67 | (+) | 14 | 17.85 | (+) |
5 | 5.27 | (+) | 15 | 16.79 | (+) |
6 | 4.48 | (+) | 16 | 11.08 | (+) |
7 | 2.95 | (+) | 17 | 2.86 | (+) |
8 | 6.08 | (+) | 18 | 3.36 | (+) |
9 | 1.02 | (+) | 19 | 22.37 | (+) |
10 | 3.60 | (+) | 20 | 24.54 | (+) |
实验号 | 信/噪比 | 结果 | 实验号 | 信/噪比 | 结果 |
1 | 0.00 | (-) | 11 | 0.00 | (-) |
2 | 0 00 | (-) | 12 | 0.00 | (-) |
3 | 0.89 | (+/-) | 13 | 0.00 | (-) |
4 | 0.00 | (-) | 14 | 0.07 | (-) |
5 | 0.00 | (-) | 15 | 0.00 | (-) |
6 | 0.00 | (-) | 16 | 0.62 | (-) |
7 | 0.00 | (-) | 17 | 0.00 | (-) |
8 | 0.51 | (-) | |||
9 | 0.00 | (-) | |||
10 | 0.00 | (-) |
实验号 | 信/噪比 | 结果 | 实验号 | 信/噪比 | 结果 |
1 | 3.36 | (+) | 6 | 3.20 | (+) |
2 | 4.41 | (+) | 7 | 3.54 | (+) |
3 | 4.25 | (+) | 8 | 2.96 | (+) |
4 | 3.62 | (+) | 9 | 3.68 | (+) |
5 | 3.14 | (+) | 10 | 2.71 | (+) |
实验号 | 信/噪比 | 结果 | 实验号 | 信/噪比 | 结果 |
1 | 2.59 | (+) | 21 | 1.74 | (+) |
2 | 3.19 | (+) | 22 | 2.24 | (+) |
3 | 2.31 | (+) | 23 | 1.93 | (+) |
4 | 2.33 | (+) | 24 | 1.82 | (+) |
5 | 2.12 | (+) | 25 | 1.98 | (+) |
6 | 1.74 | (+) | 26 | 2.54 | (+) |
7 | 1.99 | (+) | 27 | 2.17 | (+) |
8 | 2.42 | (+) | 28 | 1.46 | (+) |
9 | 2.26 | (+) | 29 | 1.74 | (+) |
10 | 1.72 | (+) | 30 | 2.35 | (+) |
11 | 1.18 | (+) | 31 | 1.25 | (+) |
12 | 1.33 | (+) | 32 | 2.35 | (+) |
13 | 2.21 | (+) | 33 | 1.62 | (+) |
14 | 2.19 | (+) | 34 | 2.72 | (+) |
15 | 2.22 | (+) | 35 | 1.45 | (+) |
16 | 1.26 | (+) | 36 | 1.78 | (+) |
17 | 1.33 | (+) | 37 | 1.06 | (+) |
18 | 2.04 | (+) | 38 | 0.26 | (-) |
19 | 1.41 | (+) | 39 | 2.08 | (+) |
20 | 2.79 | (+) | 40 | 0.90 | (-) |
实验号 | 信/噪比 | 结果 | 实验号 | 信/噪比 | 结果 |
1 | 0.34 | (-) | 21 | 0.56 | (-) |
2 | 0.33 | (-) | 22 | 0.62 | (-) |
3 | 0.13 | (-) | 23 | 0.15 | (-) |
4 | 0.34 | (-) | 24 | 0.13 | (-) |
5 | 0.17 | (-) | 25 | 0.16 | (-) |
6 | 0.14 | (-) | 26 | 0.13 | (-) |
7 | 0.08 | (-) | 27 | 0.20 | (-) |
8 | 0.28 | (-) | 28 | 0.28 | (-) |
9 | 0.21 | (-) | 29 | 0.55 | (-) |
10 | 0.42 | (-) | 30 | 0.13 | (-) |
11 | 0.37 | (-) | 31 | 0.32 | (-) |
12 | 0.09 | (-) | 32 | 0.54 | (-) |
13 | 0.10 | (-) | 33 | 0.18 | (-) |
14 | 0.45 | (-) | 34 | 0.10 | (-) |
15 | 0.07 | (-) | 35 | 0.22 | (-) |
16 | 0.14 | (-) | 36 | 0.54 | (-) |
17 | 0.41 | (-) | 37 | 0.21 | (-) |
18 | 1.04 | (+) | 38 | 0.63 | (-) |
19 | 0.20 | (-) | 39 | 0.13 | (-) |
20 | 0.28 | (-) | 40 | 0.14 | (-) |
标本号 | 酶联免疫法(EIA) | 快速检测方法 | Ortho/CBC蛋白印迹法 | |||||||
AbbottHIV-1/2 | AbbottHIV-1 | 本发明HIV-1/2 | Orgenics | Murex | Trinity | |||||
信/噪比 | 结果 | 信/噪比 | 结果 | 信/噪比 | 结果 | HIV-1/2 | HIV-1 | HIV | HIV-1 | |
106-1 | 7.5 | (+++) | 8.7 | (+++) | 1.46 | (++) | (+++) | (++) | (+) | p24,GP160 |
106-3 | 2 | (+) | 7.3 | (+++) | 2.18 | (+++) | (+) | (-) | (-) | p24,GP160 |
106-8 | 15.7 | (++++) | 2.9 | (+) | 1.97 | (+++) | (-) | (+++) | (-) | P24 |
标本号 | Ortho的HCV3.0酶联免疫法 | RIBA的HCV3.0 | 本发明方法 | |||||||
信/噪比 | 结果 | c100P | c33c | c22p | NS5 | SOD | 结果 | 信/噪比 | 结果 | |
B11 | 1.18 | (+) | (-) | (+/-) | (+++) | (-) | (-) | c22(+) | 3.00 | (+++) |
B40 | 5.10 | (+++) | (+/-) | (++) | (-) | (++) | (-) | (++) | 2.02 | (++) |
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011071966A CN1141580C (zh) | 2001-02-27 | 2001-02-27 | 对艾滋病与丙型肝炎病毒抗体的联合快速检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011071966A CN1141580C (zh) | 2001-02-27 | 2001-02-27 | 对艾滋病与丙型肝炎病毒抗体的联合快速检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1305109A CN1305109A (zh) | 2001-07-25 |
CN1141580C true CN1141580C (zh) | 2004-03-10 |
Family
ID=4656146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011071966A Expired - Fee Related CN1141580C (zh) | 2001-02-27 | 2001-02-27 | 对艾滋病与丙型肝炎病毒抗体的联合快速检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1141580C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101246170B (zh) * | 2008-01-29 | 2012-09-05 | 马义才 | 一种便携式肝炎与肝硬化快速联检装置 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101246168B (zh) * | 2008-01-29 | 2013-07-24 | 马义才 | 一种便携式性病多合一快速联检装置 |
CN101839908B (zh) * | 2010-05-28 | 2014-08-20 | 李金波 | 生物体液样本定量检测装置及其检测方法 |
CN103575884A (zh) * | 2012-07-25 | 2014-02-12 | 上海纽卓生物科技有限公司 | 胶体金法丙型肝炎病毒(hcv)快速诊断试剂盒 |
CN104764877A (zh) * | 2014-05-14 | 2015-07-08 | 陈岩松 | 一种免疫层析检测方法及试纸 |
CN104502586B (zh) * | 2014-06-11 | 2017-08-29 | 陈岩松 | 一种免疫层析检测方法及试纸 |
CN109541235A (zh) * | 2018-08-19 | 2019-03-29 | 重庆早柒天生物科技股份有限公司 | 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法 |
CN113495156A (zh) * | 2020-03-20 | 2021-10-12 | 郑州达诺生物技术有限公司 | 一种酶结合物稀释液、一种amh定量检测试剂盒及其使用方法 |
CN111879938A (zh) * | 2020-06-16 | 2020-11-03 | 烟台市疾病预防控制中心 | 一种快速检测嘧霉胺残留的量子点免疫层析试纸条及制备方法 |
-
2001
- 2001-02-27 CN CNB011071966A patent/CN1141580C/zh not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101246170B (zh) * | 2008-01-29 | 2012-09-05 | 马义才 | 一种便携式肝炎与肝硬化快速联检装置 |
Also Published As
Publication number | Publication date |
---|---|
CN1305109A (zh) | 2001-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1168985C (zh) | 带有分离器的免疫色谱分析装置 | |
FI76888B (fi) | Nya medel och foerpackningar foer immunologiska analyser. | |
JP3214854B2 (ja) | カード上での微量分析 | |
CA2318459C (en) | Neutralization of polycations in a chromatographic device for whole blood use | |
CN1646913B (zh) | 敏感性免疫色原图像测试 | |
CN100582781C (zh) | 联合检测hbv前s1抗原和核心抗原的方法及诊断试剂盒 | |
AU2007332776B2 (en) | Multiple analyte immunoassay | |
EP0532762A1 (en) | Simple analyzing device | |
CN1141580C (zh) | 对艾滋病与丙型肝炎病毒抗体的联合快速检测方法 | |
EP2290367A1 (en) | Method for detecting objective substance and kit for detecting objective substance | |
CN111796096A (zh) | 一种新型冠状病毒IgGIgM抗体联合检测试剂制备方法 | |
CN111474340A (zh) | 一种用于新型冠状病毒检测的酶标记的抗原、制备方法及试剂盒与应用 | |
CN104374921A (zh) | 一种用于莱姆病鞭毛抗原免疫血清学诊断的蛋白质芯片及其制备方法和应用 | |
CN1292255C (zh) | 白斑症病毒现场检测试纸及其制备、使用方法 | |
CN1300581C (zh) | Sars病毒抗体检测方法及快速诊断试剂盒和制备方法 | |
CN1847850A (zh) | 诊断对照*** | |
CN1159580C (zh) | 胶体金层析法检测sars冠状病毒抗原的试剂 | |
Tencza et al. | Development of a fluorescence polarization-based diagnostic assay for equine infectious anemia virus | |
Campbell et al. | Rapid antigen tests | |
Xu et al. | Multiplex biomarker analysis biosensor for detection of hepatitis B virus | |
JP4199606B2 (ja) | 免疫クロマトグラフィー検査用検体前処理液、免疫クロマトグラフィー検査方法及び免疫クロマトグラフィー検査キット | |
CN1743845A (zh) | 一种蛋白芯片的检测方法 | |
CN102621301B (zh) | 一种基于硝酸纤维素膜的蛋白芯片封闭液的制备方法 | |
Forghani | Diagnosis by viral antigen detection | |
EP3371321A1 (en) | Methods and devices for detecting methanol poisoning using formate oxidase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Shengjin Biological Engineering (Shenzhen) Co., Ltd. Assignor: Zhou Siliang Contract fulfillment period: The period of performance of the contract is 2001-12-08 to the contract period Contract record no.: Contract filing No. 041000030112 Denomination of invention: Method for joint rapid detection of antibodies to AIDS and hepatitis C virus Granted publication date: 20040310 License type: Exclusive license Record date: 20041205 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENCE; TIME LIMIT OF IMPLEMENTING CONTACT:2001-12-08 TO CONTRACT Name of requester: SHENGJIN BIOTECHNOLOGY (SHENZHEN) CO., LTD. Effective date: 20041205 |
|
ASS | Succession or assignment of patent right |
Owner name: SHENGJIN BIOTECHNOLOGY (SHENZHEN) CO., LTD. Free format text: FORMER OWNER: ZHOU SILIANG Effective date: 20060915 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060915 Address after: 4, building 7, five South Village Industrial Road, Shekou 518067 Industrial Road, Shekou, Guangdong, Shenzhen Patentee after: Shengjin Biological Engineering (Shenzhen) Co., Ltd. Address before: 4, building 7, five South Village Industrial Road, Shekou 518067 Industrial Road, Shekou, Guangdong, Shenzhen Patentee before: Zhou Siliang |
|
C56 | Change in the name or address of the patentee |
Owner name: RUILAI BIOLOGICAL ENGINEERING (SHENZHEN) CO., LTD. Free format text: FORMER NAME OR ADDRESS: SHENGJIN BIOTECHNOLOGY (SHENZHEN) CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Floor 7, building 4, South Village, five industrial road, Shekou, Guangdong, Shenzhen Patentee after: RELIA BIOLOGICAL ENGINEERING (SHENZHEN) CO., LTD. Address before: Floor 7, building 4, South Village, five industrial road, Shekou, Guangdong, Shenzhen Patentee before: Shengjin Biological Engineering (Shenzhen) Co., Ltd. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040310 Termination date: 20110227 |